Form 4 for TMDX TransMedics Group, Inc.

Accepted 2022-07-12 00:00:00 ET · period of report 2022-07-11 · accession 0000899243-22-025989 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-07-12	2022-07-11	TMDX	Carey John F	VP of Ops	S - Sale+OE	$32.98	-1,500	379	-80%	-$49.5K
D	2022-07-12	2022-07-11	TMDX	Carey John F	VP of Ops	M - OptEx	$16.14	+1,500	1,879	+396%	+$24.2K
D	2022-07-12	2022-07-11	TMDX	Carey John F	VP of Ops	M - OptEx	$0.00	-1,500	6,625	-18%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-07-11	S	D	1,500	$32.98	379	D	—	—	(F2) The reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.60 to $33.49, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2	Common	Common Stock	2022-07-11	M	A	1,500	$16.14	1,879	D	—	—
3	Derivative	Stock Option (Right to Buy)	2022-07-11	M	D	1,500	$0.00	6,625	D	$16.14 · — to 2030-02-27	1,500 Common Stock	(F3) The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. As of the date of this report, the option remains subject to vesting with respect to 6,250 shares.